Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Possible fates of the dispersion of SARS-COV-2 in the Mexican context

View ORCID ProfileI. Santamaría-Holek, View ORCID ProfileV. Castaño
doi: https://doi.org/10.1101/2020.07.15.20154526
I. Santamaría-Holek
1UMDI-J, Facultad de Ciencias, Universidad Nacional Autónoma de México, Juriquilla, Querétaro, CP 76230, México
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for I. Santamaría-Holek
  • For correspondence: isholek@ciencias.unam.mx
V. Castaño
2Centro de Física Aplicada y Tecnología Avanzada, Universidad Nacional Autónoma de México, Juriquilla, Querétaro, CP 76230, México
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for V. Castaño
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

The determination of the adequate time for house confinement and when social distancing restrictions should end are now two of the main challenges that any country has to face in an effective battle against. The possibility of a new outbreak of the pandemic and how to avoid it is, nowadays, one of the primary objectives of epidemiological research. In this work, we go deep in this subject by presenting an innovative compartmental model, that explicitly introduces the number of active cases, and employing it as a conceptual tool to explore the possible fates of the dispersion of SARS-COV-2 in the Mexican context. We incorporated the impact of starting, inattention, and end of restrictive social policies on the time evolution of the pandemics via time-in-run corrections to the infection rates. The magnitude and impact on the epidemic due to post-social restrictive policies are also studied. The scenarios generated by the model can help authorities to determine an adequate time and population load that may be allowed to reassume normal activities.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This work was supported by UNAM-DGAPA under grant IN117419.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

No patients were involved in this research that used public data on the evolution of the pandemics in Mexico, particularly the official numbers of accumulated confirmed cases, recovered patients, and the number of deaths.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • Sections 1, 2 and 3 updated to clarify the model's assumptions and formulation; Figure 5 new; Section 3d is new and contains updated data

Data Availability

Supplementary material from "Possible fates of the dispersion of SARS-COV-2 in the Mexican context" submitted with DOI https://doi.org/10.5061/dryad.70rxwdbv5. All epidemiological data were taken from https://es.wikipedia.org/wiki/Pandemia_de_enfermedad_por_coronavirus_de_2020_en_Mexico which summarizes data from https://coronavirus.gob.mx/datos/

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted August 30, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Possible fates of the dispersion of SARS-COV-2 in the Mexican context
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Possible fates of the dispersion of SARS-COV-2 in the Mexican context
I. Santamaría-Holek, V. Castaño
medRxiv 2020.07.15.20154526; doi: https://doi.org/10.1101/2020.07.15.20154526
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Possible fates of the dispersion of SARS-COV-2 in the Mexican context
I. Santamaría-Holek, V. Castaño
medRxiv 2020.07.15.20154526; doi: https://doi.org/10.1101/2020.07.15.20154526

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (280)
  • Allergy and Immunology (579)
  • Anesthesia (139)
  • Cardiovascular Medicine (1944)
  • Dentistry and Oral Medicine (252)
  • Dermatology (184)
  • Emergency Medicine (333)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (698)
  • Epidemiology (11100)
  • Forensic Medicine (8)
  • Gastroenterology (623)
  • Genetic and Genomic Medicine (3164)
  • Geriatric Medicine (308)
  • Health Economics (561)
  • Health Informatics (2042)
  • Health Policy (863)
  • Health Systems and Quality Improvement (782)
  • Hematology (310)
  • HIV/AIDS (682)
  • Infectious Diseases (except HIV/AIDS) (12717)
  • Intensive Care and Critical Care Medicine (707)
  • Medical Education (317)
  • Medical Ethics (92)
  • Nephrology (334)
  • Neurology (2985)
  • Nursing (164)
  • Nutrition (463)
  • Obstetrics and Gynecology (589)
  • Occupational and Environmental Health (614)
  • Oncology (1550)
  • Ophthalmology (477)
  • Orthopedics (185)
  • Otolaryngology (266)
  • Pain Medicine (202)
  • Palliative Medicine (57)
  • Pathology (402)
  • Pediatrics (912)
  • Pharmacology and Therapeutics (381)
  • Primary Care Research (355)
  • Psychiatry and Clinical Psychology (2782)
  • Public and Global Health (5590)
  • Radiology and Imaging (1093)
  • Rehabilitation Medicine and Physical Therapy (632)
  • Respiratory Medicine (759)
  • Rheumatology (338)
  • Sexual and Reproductive Health (311)
  • Sports Medicine (289)
  • Surgery (343)
  • Toxicology (48)
  • Transplantation (159)
  • Urology (132)